TEX 34.98    Updated: 04-28-2017 $TEX Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
57
TEX 34.98    Updated: 04-28-2017 $TEX
Last Trade: 4/28/2017
Last 34.98   
Open 34.85
Previous Close 34.98
Day High / Low 35.26 / 34.41
Year High / Low 36.43 / 18.91
Volume 2,265,339
Projected Volume 2265339 (138%)
# of Trades / Projected 11,362 / 11,362
Dividend / Yield 0.36 / 1.03%
Abnormal Activity NONE
Abnormal Volume NO
Gap GAP DOWN
Candle BULLISH
Volatility Today HIGH
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 98%
From 80 Day High 98%
From 150 Day High 98%
From 40 Day Low 118%
From 80 Day Low 118%
From 150 Day Low 156%
Pivot Analysis
Price Pivot $ 34.88
Day Resistance 1 $ 35.36
Day Support 1 $ 34.51
Day Resistance 2 $ 35.73
Day Support 2 $ 34.03
Consolidations
Short Term NO
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 1,637,293
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 1,346,230
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bullish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today HIGH
Volatility Index Yesterday HIGH
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading